Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Metabolic reprogramming is an important characteristics of glioma, the most common form of malignant brain tumor. In this chapter, we aim to discuss some of the recently discovered metabolic alterations in glioma, including the dysregulated TCA cycle, amino acid, nucleotide, and lipid metabolism. We have also detailed some of the metabolomic applications in gliomas, particularly the analyses of body fluids and tissues of glioma patients. With new improvement of the technology, metabolomics will become a powerful tool to discover truly meaningful biomarkers for clinical applications in gliomas. Metabolomic studies of gliomas will also facilitate a better understanding of the molecular targets/pathways and the development of new therapeutic treatments for this devastating disease.

Citation

Sizhe Feng, Yutong Liu. Metabolomics of Glioma. Advances in experimental medicine and biology. 2021;1280:261-276

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33791988

View Full Text